Morgan Noble Healthcare Partners
Overview
Morgan Noble Healthcare Partners is a private equity investment firm that invests in growth-stage companies within the healthcare services and healthcare technology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Pendulum Therapeutics | Jun 2017 | Series A | Co-investor |
| SyntheX | Jan 2024 | Series A | Co-investor |
| Fynch Biosciences | Aug 2019 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Morgan Noble Healthcare Partners based?
Morgan Noble Healthcare Partners is headquartered in Washington D.C., United States.
When was Morgan Noble Healthcare Partners founded?
Morgan Noble Healthcare Partners was founded in 1997.
How many portfolio companies does Morgan Noble Healthcare Partners have?
Morgan Noble Healthcare Partners has 3 portfolio companies in Caplight's dataset.
What are some companies in Morgan Noble Healthcare Partners's portfolio?
Portfolio companies visible on Caplight include Pendulum Therapeutics, SyntheX, Fynch Biosciences.
What was Morgan Noble Healthcare Partners's most recent investment shown here?
Morgan Noble Healthcare Partners's most recent investment in this portfolio sample was in SyntheX in 2024.
What sectors does Morgan Noble Healthcare Partners focus on?
Morgan Noble Healthcare Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Consumer & Commerce.
What company stages does Morgan Noble Healthcare Partners focus on?
Stage focus information for Morgan Noble Healthcare Partners is not publicly available.